In the media

Science and Technology priorities – Election 2019

MEDIA RELEASE

8 May 2019 Parties use science to set themselves apart ….

The major parties have laid out their science and technology platform for Australian voters, with clear differences in their approach and vision for empowering the solutions sector.

Responding to a survey from peak body Science & Technology Australia (STA), the Coalition, the Labor Party and the Greens have all […]

2019-05-08T04:07:34+00:00 May 8th, 2019|

It’s time for a worldwide moratorium on editing human embryos

by Alan Trounson

Hear Alan Trounson discuss the issue Saturday 6 April at 12 noon on ABC Radio National’s The Science Show.

A few weeks ago, 18 scientists from seven countries took me back forty years to a time when I was involved with the first IVF birth in Australia. Why? The scientists, writing in the journal […]

2019-04-04T02:18:14+00:00 April 2nd, 2019|

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

https://health.ucsd.edu/news/releases/Pages/2019-04-01-UC-San-Diego-Health-Treats-Cancer-Patient-with-Stem-Cell-Derived-Natural-Killer-Cells.aspx

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells
Fate Therapeutics, in collaboration with UC San Diego researcher, developed first off-the-shelf immunotherapy from human induced pluripotent stem cells that is now in clinical trials.

April 01, 2019  |  Yadira Galindo

After 10 years in remission, Derek Ruff’s cancer returned, this […]

2019-04-02T02:22:48+00:00 April 2nd, 2019|

Tom’s Long Fight

Tom Long’s battle with Multiple Myeloma

Lisa Wilkinson interviewed Aussie Actor and multiple myeloma patient Tom Long on The Sunday Project to help raise awareness for blood cancer and the need for more research in Australia.  The story is heartbreaking, Tom is hanging on to hope.  Hope that a CAR-T cell treatment that he has to […]

2019-03-25T23:18:28+00:00 March 25th, 2019|

Australia is handicapped in the delivery of cell therapies, says Alan Trounson

THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer specialists being able to select from a range of treatments to supercharge a patient’s immune system, helping it eliminate cancer.

This is not a distant vision. It is happening right here, right now. A research team, […]

2019-03-21T01:00:32+00:00 March 21st, 2019|

Safer cells for immunotherapy

Cartherics Pty Ltd teams up with Canada’s panCELLa Inc to bring the power of safe cell therapy to a greater number of patients.

Cartherics and panCELLa announce collaborative agreement to develop pluripotent cell lines for cell therapy. Melbourne, Australia and Toronto, Canada – 13 February 2019

Cartherics Pty Ltd (“Cartherics”) and panCELLa Inc. (“panCELLa”) are pleased to announce […]

2019-02-13T05:02:22+00:00 February 13th, 2019|

SUPER-CHARGING THE IMMUNE SYSTEM TO FIGHT CANCER

Innovative immunotherapies for cancer are a step closer to reality thanks to an agreement between Australia’s Cartherics Pty Ltd and Seoul-based ToolGen Inc.

2019-01-22T00:16:09+00:00 January 21st, 2019|

New cancer immunotherapy approach turns immune cells into tiny anti-tumor drug factories

https://www.eurekalert.org/pub_releases/2018-12/uoc–nci120418.php

In lab and mouse experiments, UC San Diego School of Medicine researchers developed a method to leverage B cells to manufacture and secrete tumor-suppressing microRNAs

UNIVERSITY OF CALIFORNIA – SAN DIEGO

Cancer immunotherapy — efforts to better arm a patient’s own immune system to attack tumors — has shown great potential for treating some […]

2018-12-20T02:44:33+00:00 December 20th, 2018|

‘Revolutionary’ cancer drug using genetically modified cells approved (Kymriah)

Sydney Morning Herald (By Esther Han)

19 December 2018 — 12:00am

https://www.smh.com.au/national/revolutionary-cancer-drug-using-genetically-modified-cells-approved-20181217-p50msk.html

A revolutionary cancer therapy that supercharges a patient’s immune cells to hunt and destroy cancer cells has been approved for use in Australia, ushering in a new era in medicine.

Desperate patients with aggressive blood cancers who have not responded to conventional treatments have been heading […]

2018-12-20T00:05:33+00:00 December 19th, 2018|